南财智讯1月29日电，春立医疗公告，预计2025年全年归属于上市公司股东的净利润为2.45亿元—2.88亿元，同比预增96.01%—130.41%；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为2.30亿元—2.70亿元，同比预增142.80%—185.11%；主要变动原因为：2025年度，公司归属于上市公司股东的净利润及扣除非经常性损益的净利润较上年同期均实现大幅增长。报告期内，公司各产品线纳入集采后逐步释放增长潜力，同时公司持续贯彻国际化发展战略，稳步推进国际化业务布局，内外并举推动营业收入实现持续稳定健康发展。此外，公司聚焦经营管理水平提升，优化资源配置等举措，进一步提升经营效率、增强整体盈利能力，为业绩增长提供了坚实有力的支撑。
（文章来源：南方财经网）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.